Bio-Rad Laboratories Stock Price, News & Analysis
Company Description
Bio-Rad Laboratories (NYSE: BIO.B) is a publicly traded analytical laboratory instrument manufacturing company in the Laboratory Analytical Instruments sector. The company has a market capitalization of $7.5B, ranking #1,108 among all listed U.S. companies by market cap.
This page provides a comprehensive overview of BIO.B stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Bio-Rad Laboratories (BIO.B) stock last traded at $278.25. At a market capitalization of $7.5B, BIO.B is classified as a mid-cap stock with approximately 5.1M shares outstanding.
Latest News
Bio-Rad Laboratories has 10 recent news articles. Key topics include earnings, buybacks, conferences. View all BIO.B news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
BIO.B Company Profile & Sector Positioning
Bio-Rad Laboratories (BIO.B) operates in the Analytical Laboratory Instrument Manufacturing industry within the broader Laboratory Analytical Instruments sector and is listed on the NYSE.